Cargando…

Small‐molecule nanoprodrug with high drug loading and EGFR, PI3K/AKT dual‐inhibiting properties for bladder cancer treatment

Bladder cancer (BCa) is one of the most common malignancies worldwide. Although multiple efforts have been made, the 5‐year survival rate of patients with BCa remains unchanged in recent years. Overexpression of the epidermal growth factor receptor (EGFR) is found in ≈74% of BCa tissue specimens; ho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Guoyin, Song, Zewen, Ru, Yi, Zhang, Jing, Luo, Lianxiang, Yang, Wei, Wu, Hao, Jin, Haibao, Bao, Xuanwen, Wei, Di, Yan, Zhao, Qu, Haijing, Zhu, Zheng, Xue, Xiangdong, Zhou, Gang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10582605/ https://www.ncbi.nlm.nih.gov/pubmed/37933289 http://dx.doi.org/10.1002/EXP.20220141

Ejemplares similares

Nanoprodrugs of NSAIDs: Preparation and Characterization of Flufenamic Acid Nanoprodrugs
por: Lee, Bong-Seop, et al.
Publicado: (2011)

Salinomycin-Loaded Small-Molecule Nanoprodrugs Enhance Anticancer Activity in Hepatocellular Carcinoma
por: Wang, Jianguo, et al.
Publicado: (2020)

Silica nanoparticle-based dual-responsive nanoprodrug system for liver cancer therapy
por: Xia, Qing, et al.
Publicado: (2017)

Hydrophilic Fluorescent Nanoprodrug of Paclitaxel for Glioblastoma Chemotherapy
por: Daniel, Jonathan, et al.
Publicado: (2019)

Indocyanine green potentiated paclitaxel nanoprodrugs for imaging and chemotherapy
por: Xiang, Xiujuan, et al.
Publicado: (2022)

Carrier-free nanoprodrug for p53-mutated tumor therapy via concurrent delivery of zinc-manganese dual ions and ROS
por: Wang, Jinping, et al.
Publicado: (2022)

A redox-responsive dihydroartemisinin dimeric nanoprodrug for enhanced antitumor activity
por: Li, Yawei, et al.
Publicado: (2021)

An erythrocyte-delivered photoactivatable oxaliplatin nanoprodrug for enhanced antitumor efficacy and immune response
por: Wang, Na, et al.
Publicado: (2021)

The nanoprodrug of polytemozolomide combines with MGMT siRNA to enhance the effect of temozolomide in glioma
por: Xu, Haoyue, et al.
Publicado: (2022)

Reactive Oxygen Species-Activated Nanoprodrug of Ibuprofen for Targeting Traumatic Brain Injury in Mice
por: Clond, Morgan A., et al.
Publicado: (2013)

Tumor-microenvironment activated duplex genome-editing nanoprodrug for sensitized near-infrared titania phototherapy
por: Li, Zekun, et al.
Publicado: (2022)

An orthogonally activatable CRISPR-Cas13d nanoprodrug to reverse chemoresistance for enhanced chemo-photodynamic therapy
por: Liu, Zheng, et al.
Publicado: (2023)

Reduced PHLPP Expression Leads to EGFR-TKI Resistance in Lung Cancer by Activating PI3K-AKT and MAPK-ERK Dual Signaling
por: Wang, Wei, et al.
Publicado: (2021)

Microenvironment Activatable Nanoprodrug Based on Gripper-like Cyclic Phenylboronic Acid to Precisely and Effectively Alleviate Drug-induced Hepatitis
por: Zhang, Qixiong, et al.
Publicado: (2021)

CTHRC1 facilitates bladder cancer cell proliferation and invasion through regulating the PI3K/Akt signaling pathway
por: Li, Yubing, et al.
Publicado: (2019)

A GSH-Responsive Nanoprodrug System Based on Self-Assembly of Lactose Modified Camptothecin for Targeted Drug Delivery and Combination Chemotherapy
por: Hou, Chenxi, et al.
Publicado: (2020)

Microenvironment Activatable Nanoprodrug Based on Gripper-like Cyclic Phenylboronic Acid to Precisely and Effectively Alleviate Drug-induced Hepatitis: Erratum
por: Zhang, Qixiong, et al.
Publicado: (2022)

Activation of EGFR-PI3K-AKT signaling is required for Mycoplasma hyorhinis-promoted gastric cancer cell migration
por: Duan, Hongying, et al.
Publicado: (2014)

SCD1 is required for EGFR-targeting cancer therapy of lung cancer via re-activation of EGFR/PI3K/AKT signals
por: She, Kelin, et al.
Publicado: (2019)

Abnormal low expression of SFTPC promotes the proliferation of lung adenocarcinoma by enhancing PI3K/AKT/mTOR signaling transduction
por: Zuo, Baile, et al.
Publicado: (2023)

Targeting EGFR/PI3K/AKT/mTOR Signaling in Hepatocellular Carcinoma
por: Bang, Jieun, et al.
Publicado: (2023)

Exosomes from PYCR1 knockdown bone marrow mesenchymal stem inhibits aerobic glycolysis and the growth of bladder cancer cells via regulation of the EGFR/PI3K/AKT pathway
por: Li, Zhuo, et al.
Publicado: (2023)

Antihepatocarcinoma Effect of Portulaca oleracea L. in Mice by PI3K/Akt/mTOR and Nrf2/HO-1/NF-κB Pathway
por: Guoyin, Zheng, et al.
Publicado: (2017)

The Role of EGFR/PI3K/Akt/cyclinD1 Signaling Pathway in Acquired Middle Ear Cholesteatoma
por: Liu, Wei, et al.
Publicado: (2013)

Dissecting the EGFR-PI3K-AKT pathway in oral cancer highlights the role of the EGFR variant III and its clinical relevance
por: Chang, Kwang-Yu, et al.
Publicado: (2013)

JMJD8 Promotes Malignant Progression of Lung Cancer by Maintaining EGFR Stability and EGFR/PI3K/AKT Pathway Activation
por: Zhang, Bo, et al.
Publicado: (2021)

Role of dual PI3/Akt and mTOR inhibition in Waldenstrom's Macroglobulinemia
por: Sacco, Antonio, et al.
Publicado: (2010)

SKA3 promotes lung adenocarcinoma metastasis through the EGFR–PI3K–Akt axis
por: Hu, Dan-dan, et al.
Publicado: (2020)

Mitochondrial stress and activation of PI3K and Akt survival pathway in bladder ischemia
por: Yang, Jing-Hua, et al.
Publicado: (2017)

Downregulation of NEDD4L by EGFR signaling promotes the development of lung adenocarcinoma
por: Li, Guoyin, et al.
Publicado: (2022)

Upregulation of NFKBIZ affects bladder cancer progression via the PTEN/PI3K/Akt signaling pathway
por: Xu, Tao, et al.
Publicado: (2021)

EGCG inhibited bladder cancer T24 and 5637 cell proliferation and migration via PI3K/AKT pathway
por: Luo, Ke-Wang, et al.
Publicado: (2018)

miRNA-223 is an anticancer gene in human non-small cell lung cancer through the PI3K/AKT pathway by targeting EGFR
por: Ma, Hui-Ping, et al.
Publicado: (2019)

Metapristone (RU486 metabolite) suppresses NSCLC by targeting EGFR-mediated PI3K/AKT pathway
por: Shao, Jingwei, et al.
Publicado: (2017)

CAV2 promotes the growth of renal cell carcinoma through the EGFR/PI3K/Akt pathway
por: Liu, Fu, et al.
Publicado: (2018)

In Vitro Evaluation of the Neuroprotective Effect of Panax notoginseng Saponins by Activating the EGFR/PI3K/AKT Pathway
por: Wu, Shuang, et al.
Publicado: (2020)

Fangchinoline exerts antitumour activity by suppressing the EGFR-PI3K/AKT signalling pathway in colon adenocarcinoma
por: Jiang, Fengqi, et al.
Publicado: (2021)

CMTM5 inhibits the development of prostate cancer via the EGFR/PI3K/AKT signaling pathway
por: Li, Linjin, et al.
Publicado: (2022)

Differential Regulation of the EGFR/PI3K/AKT/PTEN Pathway between Low- and High-Grade Gliomas
por: Erira, Alveiro, et al.
Publicado: (2021)

Shp2 confers cisplatin resistance in small cell lung cancer via an AKT-mediated increase in CA916798
por: Yang, Xuemei, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_a963jflkbji1p1v6hft1q1ne22